![Barbara Kosacz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Kosacz
Direktor/Vorstandsmitglied bei
LEONABIO, INC.
Vermögen: 398 622 $ am 31.05.2026
Profil
Barbara A. Kosacz is currently an Independent Director at XOMA Royalty Corp.
since 2019, a Director at Biotechnology Innovation Organization, an Independent Director at LeonaBio, Inc. since 2021, and a Trustee at Keck Graduate Institute of Applied Life Sciences.
Former roles include COO, Secretary & General Counsel at Kronos Bio, Inc. from 2020 to 2024; Independent Director at Locust Walk Acquisition Corp.
in 2021; Head-International Life Sciences Practice at Cooley LLP from 2002 to 2020; Vice President at iScribe, Inc. from 2001 to 2002; Partner at Cooley LLP from 1997 to 2000; Principal at Cooley Godward LLP; Secretary at Cellerant Therapeutics, Inc., Moksha8 Pharmaceuticals, Inc., and NGM Biopharmaceuticals, Inc.; Independent Director at Phoenix Biotech Acquisition Corp.; Director at Arsenal Biosciences, Inc.; and Member of the California State Bar Association.
Education includes an undergraduate degree from Stanford University in 1980 and a graduate degree from Berkeley Law University of California.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.05.2026 | 9’557 ( 0.08% ) | 398 622 $ | 31.05.2026 | |
LEONABIO, INC. -.--% | 01.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Barbara Kosacz
| Unternehmen | Position | Beginn |
|---|---|---|
| XOMA ROYALTY CORPORATION | Direktor/Vorstandsmitglied | 01.01.2019 |
| LEONABIO, INC. | Direktor/Vorstandsmitglied | 08.03.2021 |
Keck Graduate Institute of Applied Life Sciences
 Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Barbara Kosacz
| Unternehmen | Position | Ende |
|---|---|---|
| KRONOS BIO, INC. | Geschäftsführer | 16.02.2024 |
| EFFECTOR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.08.2021 |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.07.2020 |
California State Bar Association | Corporate Officer/Principal | 15.05.2014 |
iScribe, Inc.
 iScribe, Inc. Computer Processing HardwareElectronic Technology Designs and manufactures a handheld computing product that provides electronic prescription services | Corporate Officer/Principal | 01.02.2002 |
Ausbildung von Barbara Kosacz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Moksha8 Pharmaceuticals, Inc.
 Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cooley Godward LLP
 Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
iScribe, Inc.
iScribe, Inc. Computer Processing HardwareElectronic Technology Designs and manufactures a handheld computing product that provides electronic prescription services | Electronic Technology |
Keck Graduate Institute of Applied Life Sciences
Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
California State Bar Association | |
Berkeley Law University of California
 Berkeley Law University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Technology Services |
Locust Walk Acquisition Corp.
 Locust Walk Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Phoenix Biotech Acquisition Corp.
 Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
